Relative gene expression of NF-κB and TNF-α were significantly increased in MS compared to CTRL, while DATS treatment significantly decreased the relative gene expression of NF-κB and IL-17A (Figure 9c). The gene discussed is TNF; the disease is myeloid sarcoma.